Stock Events

Stock Events

TaiGen Biopharmaceuticals Hold 

TWD8.75
0
+TWD0.00+0% Friday 05:30

Statistics

Day High
8.74
Day Low
8.74
52W High
16.4
52W Low
7.73
Volume
1,300
Avg. Volume
-
Mkt Cap
18.17M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

18NovExpected
Q3 2022
Q1 2026
Next
Next
-0.13
0.21
0.54
0.87
Expected EPS
N/A
Actual EPS
N/A

Financials

17.41%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
259.47MRevenue
45.18MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Show more...
CEO
Kuo-Lung Huang
Employees
52
Country
Taiwan
ISIN
KYG866171005

Listings

TWO
TW
4157.TWO

0 Comments

Share your thoughts

FAQ

What is TaiGen Biopharmaceuticals Hold stock price today?▼
The current price of 4157.TWO is TWD8.75 TWD — it has increased by +0% in the past 24 hours. Watch TaiGen Biopharmaceuticals Hold stock price performance more closely on the chart.
What is TaiGen Biopharmaceuticals Hold stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange TaiGen Biopharmaceuticals Hold stocks are traded under the ticker 4157.TWO.
Is TaiGen Biopharmaceuticals Hold stock price growing?▼
4157.TWO stock has fallen by -2.67% compared to the previous week, the month change is a +1.63% rise, over the last year TaiGen Biopharmaceuticals Hold has showed a -9.7% decrease.
What is TaiGen Biopharmaceuticals Hold market cap?▼
Today TaiGen Biopharmaceuticals Hold has the market capitalization of 18.17M
When is the next TaiGen Biopharmaceuticals Hold earnings date?▼
TaiGen Biopharmaceuticals Hold is going to release the next earnings report on November 18, 2026.
What is TaiGen Biopharmaceuticals Hold revenue for the last year?▼
TaiGen Biopharmaceuticals Hold revenue for the last year amounts to 259.47M TWD.
What is TaiGen Biopharmaceuticals Hold net income for the last year?▼
4157.TWO net income for the last year is 45.18M TWD.
How many employees does TaiGen Biopharmaceuticals Hold have?▼
As of September 05, 2026, the company has 52 employees.
In which sector is TaiGen Biopharmaceuticals Hold located?▼
TaiGen Biopharmaceuticals Hold operates in the Health & Wellness sector.
When did TaiGen Biopharmaceuticals Hold complete a stock split?▼
TaiGen Biopharmaceuticals Hold has not had any recent stock splits.
Where is TaiGen Biopharmaceuticals Hold headquartered?▼
TaiGen Biopharmaceuticals Hold is headquartered in Taipei, Taiwan.